Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-17
2011-05-17
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S312000, C514S322000, C514S375000
Reexamination Certificate
active
07943623
ABSTRACT:
A pharmaceutical composition according to the present invention comprises: (I) at least one member selected from the group consisting of oxazole compounds, optically active isomers thereof, and salts thereof, the oxazole compounds being represented by general formula (1): wherein R1represents a hydrogen atom or C1-6alkyl group; n represents an integer from 0 to 6; and R2represents, for example, a group of general formula (A) shown below: wherein R3represents a phenoxy group, optionally substituted on the phenyl ring with one or more members selected from the group consisting of halogen atoms, halo-substituted or unsubstituted C1-6alkyl groups, and halo-substituted or unsubstituted C1-6alkoxy groups; and (II) at least one cellulose compound selected from the group consisting of hydroxypropyl methylcellulose phthalate and hydroxypropyl methylcellulose acetate succinate. The present pharmaceutical composition has an improved oxazole compound water solubility.
REFERENCES:
patent: 7262212 (2007-08-01), Tsubouchi et al.
patent: 0 901 786 (1999-03-01), None
patent: 1 553 088 (2005-07-01), None
patent: 2004-149527 (2004-05-01), None
patent: 03/063833 (2003-08-01), None
patent: 2005/042542 (2005-02-01), None
Kuppuswamy Nagarajan, et al.: Nitroimidazoles XXI 2,3-dihydro-6-nitroimidazo[2,1-b] oxazoles with antitubercular activity; Eur. J. Med. Chem 24 (1989) 631-633.
Dilip R. Ashtekar, et al.: In Vitro and in Vivo Activities of the Nitroimidazole CGI 17341 againstMycobacterium tuberculosis; Antimicrobial Agents and Chemotherapy, Feb. 1993, p. 183-186; vol. 37, No. 2.
Henley, III Raymond J
Otsuka Pharmaceutical Co. Ltd.
Sughrue & Mion, PLLC
LandOfFree
Pharmaceutical composition comprising... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition comprising..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2650634